Immune to Cancer: The CRI Blog




Patient Immunotherapy Summit: Ovarian Cancer Brief

It is important for the public to be aware of the scope of ovarian cancer, as over 80% of patients will experience a recurrence of the disease. Kunle Odunsi, MD, PhD, the Director of the University of Chicago Medicine Comprehensive Cancer Center and CRI Scientific Advisory Council associate director, is an expert on ovarian cancer and a titan in the field of cancer immunotherapy research.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.